AIEAX
Price
$19.10
Change
+$0.49 (+2.63%)
Updated
Jun 11 closing price
Net Assets
578.74M
TRWTX
Price
$28.14
Change
+$0.74 (+2.70%)
Updated
Jun 11 closing price
Net Assets
4.18B
Interact to see
Advertisement

AIEAX vs TRWTX

Header iconAIEAX vs TRWTX Comparison
Open Charts AIEAX vs TRWTXBanner chart's image
AIEAX vs TRWTX Comparison Chart in %
View a ticker or compare two or three
VS
AIEAX vs. TRWTX commentary
Jun 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AIEAX is a Hold and TRWTX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
TRWTX has more cash in the bank: 4.18B vs. AIEAX (579M). TRWTX pays higher dividends than AIEAX: TRWTX (3.44) vs AIEAX (2.56). AIEAX was incepted earlier than TRWTX: AIEAX (16 years) vs TRWTX (34 years). AIEAX (1.23) is less costly to investors than TRWTX (0.76). AIEAX is a more actively managed with annual turnover of: 49.00 vs. TRWTX (13.00). TRWTX has a lower initial minimum investment than AIEAX: TRWTX (0) vs AIEAX (2500). TRWTX annual gain was more profitable for investors over the last year : 16.33 vs. AIEAX (9.97). TRWTX return over 5 years is better than : 40.92 vs. AIEAX (7.98).
AIEAXTRWTXAIEAX / TRWTX
Total Expense Ratio1.230.76162%
Annual Report Gross Expense Ratio1.230.76162%
Fund Existence16 years34 years-
Gain YTD6.8238.86077%
Front Load6%N/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets579M4.18B14%
Annual Yield % from dividends2.563.4475%
Returns for 1 year9.9716.3361%
Returns for 3 years18.6151.7336%
Returns for 5 years7.9840.9219%
Returns for 10 years41.47107.3939%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DELL391.4521.62
+5.85%
Dell Technologies
IMVT32.881.70
+5.45%
Immunovant
KMPR24.780.06
+0.24%
Kemper Corp
GRCE2.30-0.01
-0.43%
Grace Therapeutics Inc
ORGO2.38-0.09
-3.64%
Organogenesis Holdings